Patient suffering and the humanized ICU: where do non-pharmacological interventions fit?
To aid in conceptualizing non-pharmacologic interventions in the ICU, we propose an adaptation of the Loeser pain and suffering model [9] . This model highlights the inter-relatedness of physiologic and emotional suffering, and the importance of interdisciplinary care in recovery from disease ( Fig. 1 ). In the model, the innermost circle represents physiologic burden where patients sustain physiologic changes, such as hypoxia or hypotension, and require medical interventions, such as mechanical ventilation or vasopressors. The second circle represents suffering, which includes the patient's thoughts (e.g., "I am short of breath. I am dying;" "I am a burden and worthless;" "Walking while critically ill will harm me") and emotions (e.g., anxiety, sadness, and loneliness) about their physiologic and environmental experience. Non-pharmacologic interventions to alleviate suffering can include education, psychological support, and other methods to reduce distress (e.g., cognitive-behavioral therapy, animal-assisted intervention, and music intervention). The third circle represents behavior, wherein worsening of physiologic burden and suffering can change patient engagement in medical and/or rehabilitation care (e.g., disengagement in rehabilitation, avoidance of medical information, declining recommended medical interventions). In the behavior realm, interventions (e.g., early mobility and motivational interviewing) move patients toward action and reinforce their role as participants in their own recovery.
Interventions in one circle have the potential to influence outcomes in other domains. Equally important is acknowledging that the patients' experiences at each level are real even if they are difficult to observe and measure. Increased attention to both patient suffering and behavior domains ensures comprehensive care and potentially better longterm outcomes.
AAI: an exemplar of a non-pharmacologic intervention to reduce suffering and encourage recovery behavior Some healthcare facilities have integrated AAI, in populations ranging from pediatrics to geriatrics, in order to reduce suffering and promote recovery behavior. Existing literature suggests that AAI reduces symptoms of anxiety and depression [10, 11] , promotes engagement in rehabilitation therapies [12] , and eases distressing physiologic symptoms (e.g., pain) [13] . Data regarding AAI in the ICU are scant, with narratives suggesting that animal presence is beneficial to patients [14] . Hypothesized mechanisms for the benefit of AAI (and potentially other non-pharmacologic interventions) are outlined in Fig. 2 . Further research regarding potential benefits is needed to build the case for animal presence in the humanized ICU. Anecdotal evidence suggests that a dog sitting in a patient's lap eases suffering and builds motivation in ways that medical interventions may not (Fig. 3) .
Implementing an AAI program for the ICU
Building new, non-pharmacologic interventions, with the intention to reduce suffering and optimize health behavior change, takes a concerted, multidisciplinary effort. Although we use the exemplar of AAI, the following program building process may apply to other nonpharmacological interventions.
We have identified six critical success factors for program building: (1) designating a champion who is consistently present in the ICU with established credibility to create systematic change; (2) having clear program goals with milestones and measurable outcomes, such as (a) improving patient mood, (b) improving engagement in medical care and rehabilitation therapies, and (c) reducing perceived pain; (3) including stakeholders who can help identify and surmount barriers to implementation (Table 1) (6) launching the program with patients who have a high likelihood of success, such as patients without delirium, communicable disease, or the need for contact precautions due to colonization with a drug-resistant microorganism, to build confidence and create momentum for the program.
Summary
As critical care medicine is increasingly successful in preventing death, the field is more focused on optimizing patients' survivorship experience. Through creating humanized ICU environments and implementing nonpharmacologic interventions, patients no longer must wait for hospital discharge before they begin to live again. Non-pharmacological intervention programs, such as AAI, may reduce suffering and help patients take an active role in their recovery. 
